- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | First Faculty of Medicine, Second Faculty of Medicine
- Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy2016 | Publication without faculty affiliation
- The 12p13.33/RAD52 Locus and Genetic Susceptibility to Squamous Cell Cancers of Upper Aerodigestive Tract2015 | First Faculty of Medicine
- Expression of GFP-mTalin reveals an actin-related role for the Arabidopsis Class II formin AtFH122012 | Faculty of Science
- Olaparib - the first PARP inhibitor in the treatment of malignant tumors2015 | First Faculty of Medicine
- Prp45 Affects Prp22 Partition in Spliceosomal Complexes and Splicing Efficiency of Non-Consensus Substrates2009 | Faculty of Science
- The development of ataxia telangiectasia mutated kinase inhibitors2014 | Publication without faculty affiliation
- Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma2016 | First Faculty of Medicine, Second Faculty of Medicine
- BRCA1 and BRCA2 - pathologist's starting kit2016 | Second Faculty of Medicine
- Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells2018 | Publication without faculty affiliation
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine